190 related articles for article (PubMed ID: 25193065)
1. Weibull regression with Bayesian variable selection to identify prognostic tumour markers of breast cancer survival.
Newcombe PJ; Raza Ali H; Blows FM; Provenzano E; Pharoah PD; Caldas C; Richardson S
Stat Methods Med Res; 2017 Feb; 26(1):414-436. PubMed ID: 25193065
[TBL] [Abstract][Full Text] [Related]
2. Bayesian variable selection and estimation in semiparametric joint models of multivariate longitudinal and survival data.
Tang AM; Zhao X; Tang NS
Biom J; 2017 Jan; 59(1):57-78. PubMed ID: 27667731
[TBL] [Abstract][Full Text] [Related]
3. Bayesian inference of the Weibull model based on interval-censored survival data.
Guure CB; Ibrahim NA; Adam MB
Comput Math Methods Med; 2013; 2013():849520. PubMed ID: 23476718
[TBL] [Abstract][Full Text] [Related]
4. Bayesian variable selection in the accelerated failure time model with an application to the surveillance, epidemiology, and end results breast cancer data.
Zhang Z; Sinha S; Maiti T; Shipp E
Stat Methods Med Res; 2018 Apr; 27(4):971-990. PubMed ID: 28034170
[TBL] [Abstract][Full Text] [Related]
5. An algorithm for direct causal learning of influences on patient outcomes.
Rathnam C; Lee S; Jiang X
Artif Intell Med; 2017 Jan; 75():1-15. PubMed ID: 28363452
[TBL] [Abstract][Full Text] [Related]
6. Boosting the discriminatory power of sparse survival models via optimization of the concordance index and stability selection.
Mayr A; Hofner B; Schmid M
BMC Bioinformatics; 2016 Jul; 17():288. PubMed ID: 27444890
[TBL] [Abstract][Full Text] [Related]
7. Gene selection in cancer classification using sparse logistic regression with Bayesian regularization.
Cawley GC; Talbot NL
Bioinformatics; 2006 Oct; 22(19):2348-55. PubMed ID: 16844704
[TBL] [Abstract][Full Text] [Related]
8. Imputation and variable selection in linear regression models with missing covariates.
Yang X; Belin TR; Boscardin WJ
Biometrics; 2005 Jun; 61(2):498-506. PubMed ID: 16011697
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical Bayesian formulations for selecting variables in regression models.
Rockova V; Lesaffre E; Luime J; Löwenberg B
Stat Med; 2012 May; 31(11-12):1221-37. PubMed ID: 22275239
[TBL] [Abstract][Full Text] [Related]
10. Bayesian variable selection for parametric survival model with applications to cancer omics data.
Duan W; Zhang R; Zhao Y; Shen S; Wei Y; Chen F; Christiani DC
Hum Genomics; 2018 Nov; 12(1):49. PubMed ID: 30400837
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
12. Ridle for sparse regression with mandatory covariates with application to the genetic assessment of histologic grades of breast cancer.
Zhai J; Hsu CH; Daye ZJ
BMC Med Res Methodol; 2017 Jan; 17(1):12. PubMed ID: 28122498
[TBL] [Abstract][Full Text] [Related]
13. The reciprocal Bayesian LASSO.
Mallick H; Alhamzawi R; Paul E; Svetnik V
Stat Med; 2021 Sep; 40(22):4830-4849. PubMed ID: 34126655
[TBL] [Abstract][Full Text] [Related]
14. Kernel-imbedded Gaussian processes for disease classification using microarray gene expression data.
Zhao X; Cheung LW
BMC Bioinformatics; 2007 Feb; 8():67. PubMed ID: 17328811
[TBL] [Abstract][Full Text] [Related]
15. 67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer.
Gasparini G; Barbareschi M; Boracchi P; Bevilacqua P; Verderio P; Dalla Palma P; Ménard S
Int J Cancer; 1995 Mar; 60(5):604-10. PubMed ID: 7860133
[TBL] [Abstract][Full Text] [Related]
16. Bayesian adaptive lasso for additive hazard regression with current status data.
Wang C; Li Q; Song X; Dong X
Stat Med; 2019 Sep; 38(20):3703-3718. PubMed ID: 31197854
[TBL] [Abstract][Full Text] [Related]
17. Model-based survival estimates of female breast cancer data.
Khan HM; Saxena A; Gabbidon K; Rana S; Ahmed NU
Asian Pac J Cancer Prev; 2014; 15(6):2893-900. PubMed ID: 24761921
[TBL] [Abstract][Full Text] [Related]
18. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis for white non-Hispanic female breast cancer patients.
Khan HM; Saxena A; Gabbidon K; Stewart TS; Bhatt C
Asian Pac J Cancer Prev; 2014; 15(9):4049-54. PubMed ID: 24935595
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.
Ali HR; Dawson SJ; Blows FM; Provenzano E; Pharoah PD; Caldas C
Breast Cancer Res; 2011; 13(6):R118. PubMed ID: 22112299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
